There is always hope—even now that immunization with beta-amyloid has not busted international psychogeriatrics; now that a term once so popular in European neuropsychiatry—“Parkinson plus”—has been de-constructed with the tools of a smart modern neurology (and that dementia with Lewy bodies has been reinvented); now that molecular biology has left some temporary responsibility for clinicians dealing with demented patients themselves, would it not be thrilling to attempt a fundamental reconsideration of some basic concepts of great—albeit temporary—practical relevance?